Half the amount of chemo prevents testicular cancer from coming back, new trial shows

byInstitute of Cancer ResearchMicrograph of seminoma testes showing lobules of uniform cells separated by delicate septae of fibrous tissue. Credit: Calicut Medical College via Wikimedia. Licens

Updated on: December 22,2023 23

Half the amount of chemo prevents testicular cancer from coming back, new trial shows

byInstitute of Cancer ResearchMicrograph of seminoma testes showing lobules of uniform cells separated by delicate septae of fibrous tissue. Credit: Calicut Medical College via Wikimedia. Licens

Updated on:December 22,2023 23

How cancer cells move and metastasize is influenced by the fluids surrounding them

by Yizeng Li,The ConversationCredit: CC0 Public DomainCell migration, or how cells move in the body, is essential to both normal body function and disease progression. Cell movement is what allo

Updated on: December 18,2023 13

How cancer cells move and metastasize is influenced by the fluids surrounding them

by Yizeng Li,The ConversationCredit: CC0 Public DomainCell migration, or how cells move in the body, is essential to both normal body function and disease progression. Cell movement is what allo

Updated on:December 18,2023 13

Differences in animal biology can affect cancer drug development

byWeill Cornell Medical CollegeDifferential co-occurrence and effects of KRAS, TP53 and LKB1 mutations on human and mouse LUADs (A) MSK Impact oncoprint of co-occurrence of KRAS, TP53 and LKB1 m

Updated on: December 20,2023 10

Differences in animal biology can affect cancer drug development

byWeill Cornell Medical CollegeDifferential co-occurrence and effects of KRAS, TP53 and LKB1 mutations on human and mouse LUADs (A) MSK Impact oncoprint of co-occurrence of KRAS, TP53 and LKB1 m

Updated on:December 20,2023 10

Cancer cells hijack enhancer DNA to grow faster, study finds

University of Toronto (U of T) researchers have found that cancer cells can enhance tumor growth by hijacking enhancer DNA normally used when tissues and organs are formed. The mechanism, called enhan

Updated on: October 30,2023 25

Cancer cells hijack enhancer DNA to grow faster, study finds

University of Toronto (U of T) researchers have found that cancer cells can enhance tumor growth by hijacking enhancer DNA normally used when tissues and organs are formed. The mechanism, called enhan

Updated on:October 30,2023 25

Researchers find the key to genome-modifying drugs' sensitivity in malignant blood diseases

by Josep Carreras Leukaemia Research InstituteImpact of azacitidine on global DNA methylation patterns and definition of EPIAZA signature in patients with MDS. (A) Study design and workflow. (B,

Updated on: March 20,2024 11

Researchers find the key to genome-modifying drugs' sensitivity in malignant blood diseases

by Josep Carreras Leukaemia Research InstituteImpact of azacitidine on global DNA methylation patterns and definition of EPIAZA signature in patients with MDS. (A) Study design and workflow. (B,

Updated on:March 20,2024 11

Online testing tool identifies people likely to benefit from genetic testing for inherited risk for certain cancers

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainAn online tool developed by researchers and physicians at Dana-Farber Cancer Institute can accurately and rapidly identify people

Updated on: December 18,2023 24

Online testing tool identifies people likely to benefit from genetic testing for inherited risk for certain cancers

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainAn online tool developed by researchers and physicians at Dana-Farber Cancer Institute can accurately and rapidly identify people

Updated on:December 18,2023 24

Targeting treatment resistance in chronic lymphocytic leukemia with a compound that goes beyond current BTK inhibitors

by University of Miami Leonard M. Miller School of MedicineCredit: Unsplash/CC0 Public DomainNew research from Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Me

Updated on: June 11,2024 4

Targeting treatment resistance in chronic lymphocytic leukemia with a compound that goes beyond current BTK inhibitors

by University of Miami Leonard M. Miller School of MedicineCredit: Unsplash/CC0 Public DomainNew research from Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Me

Updated on:June 11,2024 4

Relapse Following CAR T-cell Therapy Linked to Poor OS in Relapsed/Refractory Myeloma

August 27, 2022Lisa AstorRelapse following treatment with BCMA-directed CAR T-cell therapy was associated with poor survival outcomes in patients with relapsed/refractory multiple myeloma.Multiple Mye

Updated on: October 24,2023 31

Relapse Following CAR T-cell Therapy Linked to Poor OS in Relapsed/Refractory Myeloma

August 27, 2022Lisa AstorRelapse following treatment with BCMA-directed CAR T-cell therapy was associated with poor survival outcomes in patients with relapsed/refractory multiple myeloma.Multiple Mye

Updated on:October 24,2023 31

Detailed diagnosis boosts child cancer survival

byCancer Research UK| News6 March 2009More accurate disease classification now means some young children with neuroblastoma will have less intensive treatment with better survival, accordi

Updated on: December 19,2023 8

Detailed diagnosis boosts child cancer survival

byCancer Research UK| News6 March 2009More accurate disease classification now means some young children with neuroblastoma will have less intensive treatment with better survival, accordi

Updated on:December 19,2023 8

Single-cell 'atlas' reveals origin of an aggressive brain tumor

byCincinnati Children's Hospital Medical CenterChartshows that mice with reduced activity of either the SOX11 or HNRNOH1 genes had longer survival times when induced to develop medullo

Updated on: December 20,2023 10

Single-cell 'atlas' reveals origin of an aggressive brain tumor

byCincinnati Children's Hospital Medical CenterChartshows that mice with reduced activity of either the SOX11 or HNRNOH1 genes had longer survival times when induced to develop medullo

Updated on:December 20,2023 10

Immunotherapy improves survival in metastatic or recurrent head and neck cancer

byEuropean Society for Medical OncologyProf Barbara Burtness, Yale School of Medicine and Co-Director, Development Therapeutics Research Program, Yale Cancer Center, New Haven, US, study author.

Updated on: December 18,2023 18

Immunotherapy improves survival in metastatic or recurrent head and neck cancer

byEuropean Society for Medical OncologyProf Barbara Burtness, Yale School of Medicine and Co-Director, Development Therapeutics Research Program, Yale Cancer Center, New Haven, US, study author.

Updated on:December 18,2023 18

Third-generation anti-CD19 CAR T-cells show efficacy without neurotoxicity in B-cell lymphoma phase 1 clinical trial

byMalaghan Institute of Medical ResearchMalaghan Institute GMP lab where CAR T-cells were manufactured for the phase 1 trial. Credit: Malaghan Institute of Medical ResearchThe Malaghan Institute

Updated on: January 26,2024 23

Third-generation anti-CD19 CAR T-cells show efficacy without neurotoxicity in B-cell lymphoma phase 1 clinical trial

byMalaghan Institute of Medical ResearchMalaghan Institute GMP lab where CAR T-cells were manufactured for the phase 1 trial. Credit: Malaghan Institute of Medical ResearchThe Malaghan Institute

Updated on:January 26,2024 23